Cantor Fitzgerald initiated coverage on shares of U.S. Physical Therapy, Inc. (NYSE:USPH) in a report released on Monday. The firm issued an overweight rating and a $72.00 price objective on the stock.
“Pure play on physical therapy. We believe that outpatient services are well positioned for growth in a value-based reimbursement environment, and that outpatient physical therapy clinics are particularly well-suited for the growing post-acute care market, because they provide cost-effective care in an appropriate setting, can reduce unanticipated hospital readmissions and can lower the need for more complicated surgical procedures and related costs.”,” the firm’s analyst commented.
Other equities analysts have also recently issued reports about the stock. Zacks Investment Research raised shares of U.S. Physical Therapy from a hold rating to a buy rating and set a $69.00 target price for the company in a research note on Friday, June 23rd. Jefferies Group LLC reissued a hold rating and issued a $63.00 target price on shares of U.S. Physical Therapy in a research note on Friday, June 30th. Finally, Barrington Research raised U.S. Physical Therapy from a market perform rating to an outperform rating and set a $68.00 price target for the company in a report on Monday, July 3rd. One analyst has rated the stock with a sell rating, two have given a hold rating and three have issued a buy rating to the stock. The company has an average rating of Hold and a consensus price target of $68.00.
Shares of U.S. Physical Therapy (USPH) traded up 2.71% during mid-day trading on Monday, hitting $64.50. 16,076 shares of the stock were exchanged. The firm has a 50-day moving average price of $62.75 and a 200 day moving average price of $66.71. U.S. Physical Therapy has a 12-month low of $51.96 and a 12-month high of $78.00. The company has a market capitalization of $811.28 million, a PE ratio of 38.86 and a beta of 1.06.
U.S. Physical Therapy (NYSE:USPH) last released its earnings results on Thursday, June 29th. The company reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.49 by $0.02. U.S. Physical Therapy had a net margin of 6.44% and a return on equity of 12.44%. The business had revenue of $97.57 million during the quarter, compared to analysts’ expectations of $97.60 million. On average, equities research analysts expect that U.S. Physical Therapy will post $2.14 earnings per share for the current year.
ILLEGAL ACTIVITY NOTICE: “U.S. Physical Therapy, Inc. (USPH) Coverage Initiated by Analysts at Cantor Fitzgerald” was reported by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this story on another site, it was stolen and republished in violation of U.S. and international trademark & copyright law. The original version of this story can be viewed at https://stocknewstimes.com/2017/07/25/u-s-physical-therapy-inc-usph-coverage-initiated-by-analysts-at-cantor-fitzgerald.html.
The firm also recently declared a quarterly dividend, which was paid on Friday, July 7th. Shareholders of record on Friday, June 16th were issued a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 1.27%. The ex-dividend date was Wednesday, June 14th. U.S. Physical Therapy’s dividend payout ratio is 42.33%.
A number of large investors have recently made changes to their positions in the stock. Invictus RG acquired a new stake in shares of U.S. Physical Therapy during the first quarter valued at about $100,000. Sei Investments Co. increased its stake in shares of U.S. Physical Therapy by 9.0% in the first quarter. Sei Investments Co. now owns 1,954 shares of the company’s stock valued at $128,000 after buying an additional 162 shares in the last quarter. State of Alaska Department of Revenue increased its stake in shares of U.S. Physical Therapy by 77.8% in the second quarter. State of Alaska Department of Revenue now owns 2,454 shares of the company’s stock valued at $148,000 after buying an additional 1,074 shares in the last quarter. Mason Street Advisors LLC increased its stake in shares of U.S. Physical Therapy by 7.0% in the first quarter. Mason Street Advisors LLC now owns 2,928 shares of the company’s stock valued at $191,000 after buying an additional 192 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. acquired a new stake in shares of U.S. Physical Therapy during the first quarter valued at about $221,000. 96.40% of the stock is owned by institutional investors and hedge funds.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.
Receive News & Ratings for U.S. Physical Therapy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
